.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Healthtrust
Express Scripts
Fish and Richardson
McKinsey
Accenture
Teva
Cipla
Julphar

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078323

« Back to Dashboard
NDA 078323 describes NORETHINDRONE AND ETHINYL ESTRADIOL, which is a drug marketed by Mylan Labs Ltd, Watson Labs, Accord Hlthcare, Watson Pharms Teva, Mayne Pharma, Watson Labs Teva, Lupin Ltd, Barr, Apil, and Amneal Pharms, and is included in twenty-four NDAs. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the NORETHINDRONE AND ETHINYL ESTRADIOL profile page.

The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for NDA: 078323

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 078323

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORETHINDRONE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone
TABLET;ORAL-28 078323 ANDA Watson Pharma, Inc. 52544-953 52544-953-28 6 BLISTER PACK in 1 CARTON (52544-953-28) > 1 KIT in 1 BLISTER PACK
NORETHINDRONE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone
TABLET;ORAL-28 078323 ANDA Physicians Total Care, Inc. 54868-6273 54868-6273-0 1 BLISTER PACK in 1 CARTON (54868-6273-0) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;0.4MG
Approval Date:Feb 4, 2010TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Harvard Business School
Daiichi Sankyo
Chubb
Fuji
UBS
Express Scripts
Cerilliant
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot